Inao T, Okada K, Yang Y, Yokota I. Simulation studies on the estimation of sensitivity and specificity in the absence of a gold standard and with rare positive frequencies. Commun Stat Simul Comput. [Epub ahead of print]
Presentation at ENAR 2023 spring meeting
Inao T, Yokota I. Exact sequential single-arm trial design with curtailment for binary endpoint. ENAR 2023 Spring Meeting. 2023/3/19. Nashville, TN. Fuyama K, Yokota I. Probabilistic index for survival analysis using landmark time, clinically significant differences, and multiple prioritized endpoints: a simulation study. ENAR 2023 Spring Meeting. 2023/3/19. Nashville, TN.
Unoki’s paper is published in Viruses
Nakakubo S*, Unoki Y*, Kitajima K, Terada M, Gatanaga H, Ohmagari N, Yokota I, Konno S. Serum Lactate Dehydrogenase Level One Week after Admission Is the Strongest Predictor of Prognosis of COVID-19: A Large Observational Study Using the COVID-19 Registry Japan. Viruses. 2023; 15(3):671. https://doi.org/10.3390/v15030671 * Equally contributed
Fuyama’s paper is published in Statistics in Medicine
Fuyama K, Ogawa M, Mizusawa J, Kanemitsu Y, Fujita S, Kawahara T, Sakamaki K, Oba K. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons. Stat Med. 2023 Feb 27. doi: 10.1002/sim.9690. Epub ahead of print. PMID: 36849124.
Presentation at ISCB43
Okada K, Yokota I. Two one-sided test-then-pool method for clinical trials. ISCB43. 2022/8/24. Newcastle, UK.
Presentation at Japanese Classification Society 2021 symposium
Inao T, Yokota I. Comparison of sequential test for binary outcome. Japanese Classification Society2021 symposium, Okinawa, Japan, Dec 12, 2021. Okura H, Inao T, Yokota I. Estimation of restricted mean survival time for interval-censored data usingmidpoint imputation. Japanese Classification Society 2021 symposium, Okinawa, Japan, Dec 11, 2021.
Dr. Isao Yokota e-published a new paper as the first author in Travel Med Infect Dis.
Yokota I, Shane PY, Teshima T. Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine. Travel Med Infect Dis. 2021: 102127. doi: 10.1016/j.tmaid.2021.102127. Epub ahead of print.
IY, KO, YU and YY from our lab e-published a new paper in Lancet Microbe.
Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Iwasaki S, Fujisawa S, Nishida M, Teshima T. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study. Lancet Microbe. doi: 10.1016/S2666-5247(21)00092-6 Press releasehttps://www.global.hokudai.ac.jp/blog/a-rapid-antigen-test-for-sars-cov-2-in-saliva/
Dr. Isao Yokota e-published a new paper as the first author in Sci Rep.
Yokota I, Hattori T, Shane PY, Konno S, Nagasaka A, Takeyabu K, Fujisawa S, Nishida M, Teshima T. Equivalent SARS-CoV-2 viral loads by PCR between nasopharyngeal swab and saliva in symptomatic patients. Sci Rep. 2021;11:4500.
Mr. Tasuku Inao got Outstanding Student Presentation Award of Japanese Classification Society.
Inao T, Okada K, Yang Y, Yokota I. Estimation of sensitivity and specificity in the absence of a gold standard for data with rare positive frequencies. 39th Annual Research Meeting of Japanese Classification Society. 2020 Nov 7. Kyoto.
IY, KO, YU, YY and IT from our lab published a new paper in Clin Infect Dis.
Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Inao T, Sakamaki K, Iwasaki S, Hayasaka K, Sugita J, Nishida M, Fujisawa S, Teshima T. Mass screening of asymptomatic persons for SARS-CoV-2 using saliva. Clin Infect Dis. 2020 Sep 25:ciaa1388. doi: 10.1093/cid/ciaa1388. Epub ahead of print. PMID: 32976596.
Dr. Isao Yokota e-published a new paper as the first author in BMC Med Res Methodol.
Yokota I, Matsuyama Y. Dynamic prediction of repeated events data based on landmarking model: application to colorectal liver metastases data. BMC Med Res Methodol. 2019; 30: 31.